NGM BIOPHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ngm Biopharmaceuticals Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q4 2023.
  • Ngm Biopharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending December 31, 2023 was 82.9M shares, a 1.25% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 82.9M +1.02M +1.25% Dec 31, 2023 10-K 2024-03-11
Q3 2023 82.7M +1M +1.23% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 82.7M +3.25M +4.09% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 82.1M +3.97M +5.08% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 81.9M +3.92M +5.03% Dec 31, 2022 10-K 2024-03-11
Q3 2022 81.7M +4.07M +5.24% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 79.5M +2.16M +2.79% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 78.1M +1.17M +1.53% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 78M +7.38M +10.5% Dec 31, 2021 10-K 2023-02-28
Q3 2021 77.6M +8.71M +12.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 77.3M +8.57M +12.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 76.9M +8.98M +13.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 70.6M +3.63M +5.41% Dec 31, 2020 10-K 2022-03-01
Q3 2020 68.9M +2.78M +4.2% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 68.7M +2.7M +4.09% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 67.9M +60.9M +867% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 67M +60M +865% Dec 31, 2019 10-K 2021-03-15
Q3 2019 66.2M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 66M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 7.03M Mar 31, 2019 10-Q 2019-05-16
Q4 2018 6.94M Dec 31, 2018 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.